Sinopharm Group Co. Ltd.

SHTDY · OTC
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income$14,001$19,512$18,564$17,003
Dep. & Amort.$4,734$4,430$4,165$3,922
Deferred Tax$0$0$0$0
Stock-Based Comp.$0$0$0$0
Change in WC-$13,243-$3,864-$2,074-$12,101
Other Non-Cash$6,054-$2,905$309$484
Operating Cash Flow$11,546$17,173$20,964$9,308
Investing Activities
PP&E Inv.-$2,461-$1,960-$2,418-$2,256
Net Acquisitions$0-$32-$337-$488
Inv. Purchases$0-$29-$100-$75
Inv. Sales/Matur.$0$53$212$299
Other Inv. Act.-$1,290$1,023-$947$1,253
Investing Cash Flow-$3,751-$945-$3,590-$1,267
Financing Activities
Debt Repay.-$9,935$2,501$4,746-$4,785
Stock Issued$0$0$0$0
Stock Repurch.$0$0$0$0
Dividends Paid-$2,715-$2,559-$2,340-$2,153
Other Fin. Act.-$4,635-$7,586-$8,099-$7,754
Financing Cash Flow-$17,285-$7,644-$5,693-$14,693
Forex Effect-$5$2$12$3
Net Chg. in Cash-$9,495$8,587$11,692-$6,649
Supplemental Information
Beg. Cash$63,809$55,222$43,529$50,178
End Cash$54,313$63,809$55,222$43,529
Free Cash Flow$9,578$14,837$18,546$7,052
Sinopharm Group Co. Ltd. (SHTDY) Financial Statements & Key Stats | AlphaPilot